Skip to main content
Toggle navigation
Login
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Home
Browse by Poster Presenter
Browse by Poster Presenter
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
X
Xiang, Shengyan
Moffitt Cancer Center
(
P 019
)
COUMERMYCIN-A1 (CA1) IDENTIFIED AS A FIRST-IN-CLASS CDC45-MCM-GINS HELICASE INHIBITOR OFFERING THERAPEUTIC POTENTIAL FOR OSTEOSARCOMA TREATMENT
Shengyan Xiang
Favorite
Xia, Yanzhe
Department of Pharmacy, The First Affiliated Hospital of Sun Yat-sen University
(
P 101
)
CYTOREDUCTIVE SURGERY FOR METASTATIC GASTROINTESTINAL STROMAL TUMORS TREATED WITH RIPRETINIB: A SINGLE-CENTER ANALYSIS.
Yanzhe Xia
Favorite
(
P 111
)
PLASMA CONCENTRATION MONITORING AND PERSONALIZED DESENSITIZATION THERAPY IN PATIENTS OF GASTROINTESTINAL STROMAL TUMORS WITH IMATINIB-ASSOCIATED SKIN RASH
Yanzhe Xia
Favorite
Xie, Lu
Peking University People's Hospital
(
P 021
)
DISTINCT GENOMIC FEATURES BETWEEN OSTEOSARCOMAS FIRSTLY METASTASING TO BONE AND TO LUNG
Lu Xie
Favorite
Xie, Xianbiao
Department of Musculoskeletal Oncology Center, The First Affiliated Hospital of Sun Yat-sen University
(
P 164
)
PRELIMINARY PHASE 1B RESULTS OF ABSK021 FOR ADVANCED TENOSYNOVIAL GIANT CELL TUMOR: SIGNIFICANT ANTITUMOR ACTIVITY AND FAVOURABLE SAFETY PROFILE
Xianbiao Xie
Favorite
Xing, Jessica
Banner University Medical Center Tucson
(
P 208
)
STEREOTACTIC ABLATIVE BODY RADIOTHERAPY FOR PEDIATRIC OSTEOSARCOMA LUNG METASTASES
Jessica Xing
Favorite
Xu, Christina
Zentalis Pharmaceuticals
(
P 187
)
PRECLINICAL VALIDATION OF TARGET ENGAGEMENT ASSAYS AND INVESTIGATION OF MECHANISTIC IMPACTS OF FHD-609, A CLINICAL-STAGE BRD9 DEGRADER BEING DEVELOPED FOR THE TREATMENT OF SYNOVIAL SARCOMA
Christina Xu
Favorite
Xue, Wei
COG Data and Statistics Center, University of Florida
(
P 155
)
LATE EVENTS OCCURRING AFTER 5 YEARS IN PEDIATRIC RHABDOMYOSARCOMA: A REPORT FROM THE CHILDREN'S ONCOLOGY GROUP
Wei Xue
Favorite
Xu, Hairong
Department of Orthopaedic Oncology Surgery, Beijing Ji Shui Tan Hospital, Peking University
(
P 164
)
PRELIMINARY PHASE 1B RESULTS OF ABSK021 FOR ADVANCED TENOSYNOVIAL GIANT CELL TUMOR: SIGNIFICANT ANTITUMOR ACTIVITY AND FAVOURABLE SAFETY PROFILE
Hairong Xu
Favorite
Xu, Hongli
Shanghai Sixth People's Hospital
(
P 136
)
PRELIMINARY EFFICACY AND SAFETY OF FAMITINIB PLUS SHR-1701 IN ADVANCED SARCOMA: A SINGLE-CENTER, PHASE 2 TRIAL
Hongli Xu
Favorite
Xu, Jie
Peking University People’s Hospital
(
P 021
)
DISTINCT GENOMIC FEATURES BETWEEN OSTEOSARCOMAS FIRSTLY METASTASING TO BONE AND TO LUNG
Jie Xu
Favorite
Xu, Menglin
The Ohio State University Comprehensive Cancer Center
(
P 200
)
CLINICAL CHARACTERISTICS, PATTERNS OF CARE, AND TREATMENT OUTCOMES OF RADIATION-ASSOCIATED SARCOMAS
Menglin Xu
Favorite
(
P 259
)
ASSOCIATION BETWEEN AREA DEPRIVATION INDEX AND INITIAL TREATMENT AMONG PATIENTS WITH DESMOID TUMORS
Menglin Xu
Favorite
Xu, Ying Hui
University of British Columbia
(
P 074
)
EWING SARCOMA AND RHABDOMYOSARCOMA PATIENT OUTCOME VARIATIONS BASED ON TREATMENT CENTRE VOLUME
Ying Hui Xu
Favorite
Back to Top
